Publications by authors named "Michael Whyte"

Claim this Profile
C
Corrigendum to "Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631)" [Bone 197 (2025) 117477].
Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, Elizabeth Garrido-Carrasco, Jonathan C Baker, Michael P Whyte

Bone· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markedly discordant hypophosphatasia in a young girl.
Vikram Prakash, Samer Elbabaa, Richard Banks, Gabriel de Carlos, William H McAlister, Michael P Whyte

Bone· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming growth factor, beta-2 gene mutation causes autosomal dominant Camurati-Engelmann disease, type 2 (OMIM % 606631).
Steven Mumm, José L Paz-Ibarra, Philippe M Campeau, Elizabeth Garrido-Carrasco, Jonathan C Baker, Michael P Whyte

Bone· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duplications within exon 1 of TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK) are associated with tendon avulsion.
Jill H Simmons, Edna E Mancilla, Steven Mumm, Kathryn M Dahir, Shenghui Duan, Michael P Whyte

Bone· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmembrane protein 53 craniotubular dysplasia (OMIM # 619727): The skeletal disease and consequent blindness of this new disorder.
Michael P Whyte, Robert S Weinstein, Paul H Phillips, William H McAlister, Raghuhr H Ramakrishnaiah

Bone· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal fluorosis: an uncommon cause, yet a rescue treatment?
Julia Rose R Shariff, Khine Mon Swe, Neil Binkley, Michael P Whyte, Samatha K Pabich

Osteoporos Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric hypophosphatasia: avoid diagnosis missteps!
Michael P Whyte, William H McAlister, Karen E Mack, Steven Mumm, Katherine L Madson

J Bone Miner Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridoxine challenge reflects pediatric hypophosphatasia severity and thereby examines tissue-nonspecific alkaline phosphatase's role in vitamin B metabolism.
Michael P Whyte, Fan Zhang, Karen E Mack, Deborah Wenkert, Gary S Gottesman

Bone· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
Leanne M Ward, Wolfgang Högler, Francis H Glorieux, Anthony A Portale, Michael P Whyte

JBMR Plus· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
Erik A Imel, Francis H Glorieux, Michael P Whyte, Anthony A Portale, Craig F Munns

J Clin Endocrinol Metab· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopetrosis: Gene-based nosology and significance.
Anna Teti, Michael P Whyte

Bone· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced osteopetrosis.
Michael P Whyte, William H McAlister, Vandana Dhiman, Nirmal Raj Gopinathan, Sanjay K Bhadada

Bone· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopetrosis: Discovery and early history of "marble bone disease".
Michael P Whyte

Bone· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy.
Meghan Craven, Mary Ellen Vajravelu, Karuna V Shekdar, Michael A Levine, Steven Mumm, Michael P Whyte

Bone· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbonic anhydrase II deficiency.
Michael P Whyte

Bone· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low-Density Lipoprotein Receptor-Related Protein 6.
Michael P Whyte, Steven Mumm, Jonathan C Baker, Fan Zhang, Homer Sedighi

JBMR Plus· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Skeletal and extraskeletal disorders of biomineralization.
Michael T Collins, Gemma Marcucci, Hans-Joachim Anders, Giovanni Beltrami, Jane A Cauley, Michael P Whyte

Nat Rev Endocrinol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-Linked Hypophosphatemia Caused by the Prevailing North American Variant c.*231A>G; Exon 13-15 Duplication Is Often Misdiagnosed as Ankylosing Spondylitis and Manifests in Both Men and Women.
Kathryn McCrystal Dahir, Margo Black, Gary S Gottesman, Erik A Imel, Steven Mumm, Michael P Whyte

JBMR Plus· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal and extraskeletal disorders of biomineralization.
Michael T Collins, Gemma Marcucci, Hans-Joachim Anders, Giovanni Beltrami, Jane A Cauley, Michael P Whyte

Nat Rev Endocrinol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity.
Serap Turan, Steven Mumm, Ceren Alavanda, Betul Sare Kaygusuz, Busra Gurpinar Tosun, Michael P Whyte

JBMR Plus· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periarticular calcifications containing giant pseudo-crystals of francolite in skeletal fluorosis from 1,1-difluoroethane "huffing".
Nilton Salles Rosa Neto, Daniel Englert, William H McAlister, Steven Mumm, David Mills, Michael P Whyte

Bone· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.
Leanne M Ward, Francis H Glorieux, Michael P Whyte, Craig F Munns, Anthony A Portale

J Clin Endocrinol Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia.
Agnès Linglart, Erik A Imel, Michael P Whyte, Anthony A Portale, Wolfgang Högler

J Clin Endocrinol Metab· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypophosphatasia: Vitamin B status of affected children and adults.
Michael P Whyte, Fan Zhang, Deborah Wenkert, Karen E Mack, Vinieth N Bijanki

Bone· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult hypophosphatasia treated with reduced frequency of teriparatide dosing.
Stergios A Polyzos, Symeon Tournis, Antonis Goulas, Panagoula Kollia, Michael P Whyte

J Musculoskelet Neuronal Interact· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis